Rapid Diagnosis of Smear-negative Tuberculosis by Bronchoalveolar Lavage Enzyme-linked Immunospot
- 1 November 2006
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 174 (9) , 1048-1054
- https://doi.org/10.1164/rccm.200604-465oc
Abstract
Rationale: In a large proportion of patients with active pulmonary tuberculosis (pTB), acid-fast bacilli smear results for sputum and bronchial secretions are negative. Detectable growth of Mycobacterium tuberculosis (MTB) in cultures takes several weeks and MTB-specific DNA amplification results on sputum and bronchial secretions are variable in these patients. Objective: We investigated whether a rapid diagnosis of pTB can be established by enumeration of MTB-specific mononuclear cells from bronchoalveolar lavage (BAL) fluid in routine clinical practice. Methods: Patients presenting to a tertiary hospital with medical histories and pulmonary infiltrates compatible with tuberculosis, and negative acid-fast bacilli smear results (three) from sputum, were prospectively enrolled in this study. An MTB-specific enzyme-linked immunospot assay (ELISPOT [T-SPOT.TB; Oxford Immunotec, Abingdon, UK]) with early antigenic target-6 (ESAT-6) and culture filtrate protein-10 (CFP-10) peptides was performed on peripheral blood mononuclear cells (PBMCs) and mononuclear cells from the BAL fluid (BALMCs). Measurements and Main Results: Of 37 patients, 12 were found to have smear-negative pTB and 25 were found to have an alternative diagnosis. Patients with tuberculosis had a median number of 17 ESAT-6–specific cells and 24.5 CFP-10–specific cells per 200,000 PBMCs and 37.5 ESAT-6–specific cells and 49.5 CFP-10–specific cells per 200,000 cells in the BAL fluid. Control patients had a median of 1 ESAT-6–specific cell and 1 CFP-10–specific cell per 200,000 PBMCs and no ESAT-6– and CFP-10–specific cells per 200,000 cells in the BAL fluid (p < 0.0001). All patients with TB but none of the control subjects had more than 5 spot-forming cells per 200,000 BALMCs with either peptide in the BAL fluid ELISPOT. Conclusion: Smear-negative pulmonary tuberculosis can be diagnosed rapidly by identification of MTB-specific cells in the BAL fluid.Keywords
This publication has 45 references indexed in Scilit:
- Discrepancy Between the Tuberculin Skin Test and the Whole-Blood Interferon γ Assay for the Diagnosis of Latent Tuberculosis Infection in an Intermediate Tuberculosis-Burden CountryJAMA, 2005
- Diagnosis of tuberculosis in South African children with a T cell-based assay: a prospective cohort studyThe Lancet, 2004
- Comparison of Tuberculin Skin Test and New Specific Blood Test in Tuberculosis ContactsAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Stellenwert der Polymeraseketten-Reaktion (PCR) und anderer Amplifikationsverfahren in der Diagnostik der TuberkulosePneumologie, 2004
- Rapid Detection ofMycobacterium tuberculosisInfection by Enumeration of Antigen-specific T CellsAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Enumeration of T Cells Specific for RD1‐Encoded Antigens Suggests a High Prevalence of LatentMycobacterium tuberculosisInfection in Healthy Urban IndiansThe Journal of Infectious Diseases, 2001
- Use of ESAT‐6 and CFP‐10 Antigens for Diagnosis of Extrapulmonary TuberculosisThe Journal of Infectious Diseases, 2001
- Antigenic Equivalence of Human T-Cell Responses to Mycobacterium tuberculosis -Specific RD1-Encoded Protein Antigens ESAT-6 and Culture Filtrate Protein 10 and to Mixtures of Synthetic PeptidesInfection and Immunity, 2000
- Diagnostic Standards and Classification of Tuberculosis in Adults and ChildrenAmerican Journal of Respiratory and Critical Care Medicine, 2000
- A Mycobacterium tuberculosis operon encoding ESAT=6 and a novel low-molecular-mass culture filtrate protein (CFP-10)Microbiology, 1998